Related Experiment Video

Updated: Jul 2, 2026

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation
06:23

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Published on: March 9, 2018

Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et

Edward L Korn, Sally Hunsberger, Boris Freidlin

    Clinical Trials (London, England)
    |August 14, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation
    11:09

    Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

    Published on: August 1, 2018

    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
    09:08

    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

    Published on: December 20, 2024

    Related Experiment Videos

    Last Updated: Jul 2, 2026

    Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation
    06:23

    Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

    Published on: March 9, 2018

    Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation
    11:09

    Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

    Published on: August 1, 2018

    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
    09:08

    Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

    Published on: December 20, 2024

    Related Concept Videos

    Censoring Survival Data01:09

    Censoring Survival Data

    Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...

    Articles linked to this work by shared authors, journal, and citation graph.

    Two-to-one randomization is associated with increased control-arm patient withdrawal.

    Journal of the National Cancer Institute·2026

    Changing standard of care during a randomized trial: examples, considerations and guidelines.

    Journal of the National Cancer Institute·2026

    A note on rank-preserving structural failure time models to account for crossover.

    Clinical trials (London, England)·2026

    Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.

    JCO precision oncology·2025

    Consensus statement on the treatment of proximal humerus fractures: a Delphi approach by the Neer Circle of the American Shoulder and Elbow Surgeons.

    Journal of shoulder and elbow surgery·2025

    Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.

    Clinical trials (London, England)·2025

    Are safety lead-in phase II clinical trials really safe?

    Clinical trials (London, England)·2026

    Uncertainty and novel clinical trial designs in oncology - when should equipoise matter?

    Clinical trials (London, England)·2026

    New oncology trial designs and equipoise: Commentary on Heynemann et al.

    Clinical trials (London, England)·2026

    A classification of incomplete stepped wedge cluster randomised trial designs.

    Clinical trials (London, England)·2026

    How to be SMART in oncology: A practical framework to assess the contribution of phase using sequential multiple adaptive randomized treatment designs.

    Clinical trials (London, England)·2026

    A practical application for the efficient use of historical data in randomized controlled design using systematic review data.

    Clinical trials (London, England)·2026

    [The right of older persons to consent to healthcare services: selected legal issues].

    Medycyna pracy·2026

    Semantic Mapping of Public Health Legislation and Emergency Legal Responses Using Natural Language Processing Techniques.

    Risk management and healthcare policy·2026

    US jail and prison institutional research policies: a lever in access to research for incarcerated people.

    Lancet regional health. Americas·2026

    Perceptions of Medical Malpractice Liability and Informed Consent Among Hospital Healthcare Workers: A Cross-Sectional Study.

    Healthcare (Basel, Switzerland)·2026

    Pharmacist license verification in the United States: Availability, content, and transparency across jurisdictions.

    Journal of the American Pharmacists Association : JAPhA·2026

    IRB Policies on the Inclusion of Pregnant Women in Research.

    Ethics & human research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us